Regencell Bioscience Holdings (RGC) Retained Earnings (2020 - 2025)

Regencell Bioscience Holdings' Retained Earnings history runs 6 years deep, the most recent figure standing at -$30.5 million for Q4 2025.

• Quarterly Retained Earnings changed N/A year-over-year to -$30.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$30.5 million (changed N/A YoY) and the FY2025 annual result came in at -$25.2 million, down 54965.15% from the prior year.
• Retained Earnings was -$30.5 million for Q4 2025 at Regencell Bioscience Holdings, down from -$25.2 million in the prior quarter.
• Across five years, Retained Earnings topped out at $256.0 in Q2 2021 and bottomed at -$30.5 million in Q4 2025.
• A 5-year average of -$11.2 million and a median of -$5.8 million in 2022 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2021 — Retained Earnings jumped 100.01% — and 2022, when it tumbled 4470387.5%.
• Regencell Bioscience Holdings' Retained Earnings stood at $256.0 in 2021, then tumbled by 4470387.5% to -$11.4 million in 2022, then jumped by 99.24% to -$86658.0 in 2023, then soared by 47.19% to -$45766.0 in 2024, then sank by 66585.1% to -$30.5 million in 2025.
• Business Quant data shows RGC's Retained Earnings at -$30.5 million in Q4 2025, -$25.2 million in Q2 2025, and -$45766.0 in Q2 2024.